WO2001090127A3 - Haplotypes du gene de hoxd3 - Google Patents

Haplotypes du gene de hoxd3 Download PDF

Info

Publication number
WO2001090127A3
WO2001090127A3 PCT/US2001/016982 US0116982W WO0190127A3 WO 2001090127 A3 WO2001090127 A3 WO 2001090127A3 US 0116982 W US0116982 W US 0116982W WO 0190127 A3 WO0190127 A3 WO 0190127A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
hoxd3
gene
disclosed
hoxd3 gene
Prior art date
Application number
PCT/US2001/016982
Other languages
English (en)
Other versions
WO2001090127A2 (fr
Inventor
Amy Duda
Amir Kazemi
Beena Koshy
Anant Madan Kumar
Original Assignee
Genaissance Pharmaceuticals
Amy Duda
Amir Kazemi
Beena Koshy
Anant Madan Kumar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Amy Duda, Amir Kazemi, Beena Koshy, Anant Madan Kumar filed Critical Genaissance Pharmaceuticals
Priority to AU2001264966A priority Critical patent/AU2001264966A1/en
Publication of WO2001090127A2 publication Critical patent/WO2001090127A2/fr
Publication of WO2001090127A3 publication Critical patent/WO2001090127A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne de nouvelles variantes génétiques du gène de l'Homeo Box D3 (HOXD3). Elle concerne différents génotypes, haplotypes et paires d'haplotypes du gène de HOXD3 existant dans la population générale des Etats-Unis. Elle concerne également des compositions et des procédés servant à effectuer l'haplotypage et/ou le génotypage du gène de HOXD3 chez un individu. Elle concerne également des polynucléotides définis par la séquence de ces haplotypes.
PCT/US2001/016982 2000-05-25 2001-05-24 Haplotypes du gene de hoxd3 WO2001090127A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001264966A AU2001264966A1 (en) 2000-05-25 2001-05-24 Haplotypes of the hoxd3 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20707600P 2000-05-25 2000-05-25
US60/207,076 2000-05-25

Publications (2)

Publication Number Publication Date
WO2001090127A2 WO2001090127A2 (fr) 2001-11-29
WO2001090127A3 true WO2001090127A3 (fr) 2002-03-28

Family

ID=22769113

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016982 WO2001090127A2 (fr) 2000-05-25 2001-05-24 Haplotypes du gene de hoxd3

Country Status (2)

Country Link
AU (1) AU2001264966A1 (fr)
WO (1) WO2001090127A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544670B2 (en) 2001-06-14 2009-06-09 The Regents Of The University Of California HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing
US7157439B2 (en) * 2001-06-14 2007-01-02 The Regents Of The University Of California HoxD3, HoxA3, and HoxB3 compositions and methods for improved wound healing

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 26 June 1997 (1997-06-26), CIANETTI L., XP002905146, accession no. NCBI Database accession no. Y09980 *
DATABASE SNP [online] NATIONAL LIBRARY OF MEDICINE, (BETHESDA, MD, USA); 13 September 2000 (2000-09-13), XP002905147, retrieved from 1527870 accession no. NCBI Database accession no. 1051929 *
TANIGUCHI ET AL.: "Cloning and sequencing of the human homeobox gene HOX4A", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1132, 1992, pages 332 - 334, XP002905145 *
TANIGUCHI ET AL.: "Structural analysis of the human HOX4A homeobox gene", NUCLEIC ACIDS SYMPOSIUM SERIES, vol. 25, 1991, pages 31 - 32, XP002905144 *

Also Published As

Publication number Publication date
WO2001090127A2 (fr) 2001-11-29
AU2001264966A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001079228A3 (fr) Haplotypes du gene f12
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2002010454A3 (fr) Haplotypes du gene alas2? ¿
WO2001090120A3 (fr) Haplotypes du gene evx1
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2002042320A3 (fr) Haplotypes du gene de glutathione reductase
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2002038586A3 (fr) Haplotypes du gene il6
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001087907A3 (fr) Haplotypes du gene de l'osm
WO2002026765A3 (fr) Haplotypes du gene de muc1
WO2002016399A3 (fr) Haplotypes du gene tacr1

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP